Zimmer Biomet (ZBH) is scheduled to report earnings on Nov 4, 2026, before the open. The consensus estimate calls for EPS of $1.90 on revenue of $2.06B. Options are pricing a move of about ±7.0% for the first session after the report.
Across its last 8 reports, ZBH beat the EPS consensus 7 times out of 8 with a figure on file, and the stock moved an average of 7.6% on the first trading day, closing higher 4 of 8 times. That first-day move was larger than the options-implied move in 5 of 8 reports. Measured over five sessions, the average move was 8.6%.
The ±7.0% now priced is close to the 7.6% ZBH has averaged. Historically, ZBH has tended to move more than its options implied. A beat alone has not been enough: ZBH closed higher after only 3 of its 7 EPS beats. NextPick tracks ZBH in its Medical Devices basket alongside ABT, ISRG, MDT, SYK, BSX, BDX, EW and IDXX, whose prints read through to this one.
Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.